Aβ(1-15/16) as a marker for γ-secretase inhibition in Alzheimer’s disease

Amyloid-β (Aβ) producing enzymes are key targets for disease-modifying Alzheimer’s disease (AD) therapies since Aβ trafficking is at the core of AD pathogenesis. Development of such drugs might benefit from the identification of markers indicating in vivo drug effects in the central nervous system....

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Portelius, Erik, Zetterberg, Henrik, Dean, Robert A., Marcil, Alexandre, Bourgeois, Philippe, Nutu, Magdalena, Andreasson, Ulf, Siemers, Eric, Mawuenyega, Kwasi G., Sigurdson, Wendy C., May, Patrick C., Paul, Steven M., Holtzman, David M., Blennow, Kaj, Bateman, Randall J.
Формат: Artigo
Язык:Inglês
Опубликовано: 2012
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3609706/
https://ncbi.nlm.nih.gov/pubmed/22531418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-2012-120508
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы